Irene Colombo1, Mariacristina Scoto1, Adnan Y Manzur1, Stephanie A Robb1, Lorenzo Maggi1, Vasantha Gowda1, Thomas Cullup1, Michael Yau1, Rahul Phadke1, Caroline Sewry1, Heinz Jungbluth1, Francesco Muntoni2. 1. From the Dubowitz Neuromuscular Centre and MRC Centre for Neuromuscular Disorders (I.C., M.S., A.Y.M., S.A.R., V.G., C.S., F.M.), University College London Institute of Child Health and Great Ormond Street Hospital for Children, London, UK; Neuromuscular Unit (I.C.), Department of Neurological Sciences, IRCCS Foundation Cà Granda, Ospedale Maggiore Policlinico, Dino Ferrari Centre, Milan, University of Milan; Muscle Pathology and Neuroimmunology Unit (L.M.), Foundation IRCCS Neurological Institute C. Besta, Milan, Italy; DNA Laboratory (T.C., M.Y.), GSTS Pathology, Guy's Hospital, London; University College London Department of Neurology (R.P.), National Hospital for Neurology and Neurosurgery, London; Wolfson Centre for Inherited Neuromuscular Diseases RJAH (C.S.), Oswestry; Department of Paediatric Neurology (H.J.), Evelina Children's Hospital, London; Randall Division for Cell and Molecular Biophysics (H.J.), Muscle Signalling Section, King's College, London; and Clinical Neuroscience Division (H.J.), IoP, London, UK. 2. From the Dubowitz Neuromuscular Centre and MRC Centre for Neuromuscular Disorders (I.C., M.S., A.Y.M., S.A.R., V.G., C.S., F.M.), University College London Institute of Child Health and Great Ormond Street Hospital for Children, London, UK; Neuromuscular Unit (I.C.), Department of Neurological Sciences, IRCCS Foundation Cà Granda, Ospedale Maggiore Policlinico, Dino Ferrari Centre, Milan, University of Milan; Muscle Pathology and Neuroimmunology Unit (L.M.), Foundation IRCCS Neurological Institute C. Besta, Milan, Italy; DNA Laboratory (T.C., M.Y.), GSTS Pathology, Guy's Hospital, London; University College London Department of Neurology (R.P.), National Hospital for Neurology and Neurosurgery, London; Wolfson Centre for Inherited Neuromuscular Diseases RJAH (C.S.), Oswestry; Department of Paediatric Neurology (H.J.), Evelina Children's Hospital, London; Randall Division for Cell and Molecular Biophysics (H.J.), Muscle Signalling Section, King's College, London; and Clinical Neuroscience Division (H.J.), IoP, London, UK. f.muntoni@ucl.ac.uk.
Abstract
OBJECTIVE: To assess the natural history of congenital myopathies (CMs) due to different genotypes. METHODS: Retrospective cross-sectional study based on case-note review of 125 patients affected by CM, followed at a single pediatric neuromuscular center, between 1984 and 2012. RESULTS: Genetic characterization was achieved in 99 of 125 cases (79.2%), with RYR1 most frequently implicated (44/125). Neonatal/infantile onset was observed in 76%. At birth, 30.4% required respiratory support, and 25.2% nasogastric feeding. Twelve percent died, mainly within the first year, associated with mutations in ACTA1, MTM1, or KLHL40. All RYR1-mutated cases survived and did not require long-term ventilator support including those with severe neonatal onset; however, recessive cases were more likely to require gastrostomy insertion (p = 0.0028) compared with dominant cases. Independent ambulation was achieved in 74.1% of all patients; 62.9% were late walkers. Among ambulant patients, 9% eventually became wheelchair-dependent. Scoliosis of variable severity was reported in 40%, with 1/3 of (both ambulant and nonambulant) patients requiring surgery. Bulbar involvement was present in 46.4% and required gastrostomy placement in 28.8% (at a mean age of 2.7 years). Respiratory impairment of variable severity was a feature in 64.1%; approximately half of these patients required nocturnal noninvasive ventilation due to respiratory failure (at a mean age of 8.5 years). CONCLUSIONS: We describe the long-term outcome of a large cohort of patients with CMs. While overall course is stable, we demonstrate a wide clinical spectrum with motor deterioration in a subset of cases. Severity in the neonatal/infantile period is critical for survival, with clear genotype-phenotype correlations that may inform future counseling.
OBJECTIVE: To assess the natural history of congenital myopathies (CMs) due to different genotypes. METHODS: Retrospective cross-sectional study based on case-note review of 125 patients affected by CM, followed at a single pediatric neuromuscular center, between 1984 and 2012. RESULTS: Genetic characterization was achieved in 99 of 125 cases (79.2%), with RYR1 most frequently implicated (44/125). Neonatal/infantile onset was observed in 76%. At birth, 30.4% required respiratory support, and 25.2% nasogastric feeding. Twelve percent died, mainly within the first year, associated with mutations in ACTA1, MTM1, or KLHL40. All RYR1-mutated cases survived and did not require long-term ventilator support including those with severe neonatal onset; however, recessive cases were more likely to require gastrostomy insertion (p = 0.0028) compared with dominant cases. Independent ambulation was achieved in 74.1% of all patients; 62.9% were late walkers. Among ambulant patients, 9% eventually became wheelchair-dependent. Scoliosis of variable severity was reported in 40%, with 1/3 of (both ambulant and nonambulant) patients requiring surgery. Bulbar involvement was present in 46.4% and required gastrostomy placement in 28.8% (at a mean age of 2.7 years). Respiratory impairment of variable severity was a feature in 64.1%; approximately half of these patients required nocturnal noninvasive ventilation due to respiratory failure (at a mean age of 8.5 years). CONCLUSIONS: We describe the long-term outcome of a large cohort of patients with CMs. While overall course is stable, we demonstrate a wide clinical spectrum with motor deterioration in a subset of cases. Severity in the neonatal/infantile period is critical for survival, with clear genotype-phenotype correlations that may inform future counseling.
Authors: Sylvia L Anderson; Josef Ekstein; Mary C Donnelly; Erin M Keefe; Nicole R Toto; Lauretta A LeVoci; Berish Y Rubin Journal: Hum Genet Date: 2004-06-23 Impact factor: 4.132
Authors: Carina Wallgren-Pettersson; Katarina Pelin; Kristen J Nowak; Francesco Muntoni; Norma B Romero; Hans H Goebel; Kathryn N North; Alan H Beggs; Nigel G Laing Journal: Neuromuscul Disord Date: 2004-09 Impact factor: 4.296
Authors: M M Ryan; C Schnell; C D Strickland; L K Shield; G Morgan; S T Iannaccone; N G Laing; A H Beggs; K N North Journal: Ann Neurol Date: 2001-09 Impact factor: 10.422
Authors: H Jungbluth; C A Sewry; S C Brown; K J Nowak; N G Laing; C Wallgren-Pettersson; K Pelin; A Y Manzur; E Mercuri; V Dubowitz; F Muntoni Journal: Neuromuscul Disord Date: 2001-01 Impact factor: 4.296
Authors: Pankaj B Agrawal; Corinne D Strickland; Charles Midgett; Ana Morales; Daniel E Newburger; Melisa A Poulos; Kinga K Tomczak; Monique M Ryan; Susan T Iannaccone; Tom O Crawford; Nigel G Laing; Alan H Beggs Journal: Ann Neurol Date: 2004-07 Impact factor: 10.422
Authors: John C Sparrow; Kristen J Nowak; Hayley J Durling; Alan H Beggs; Carina Wallgren-Pettersson; Norma Romero; Ikuya Nonaka; Nigel G Laing Journal: Neuromuscul Disord Date: 2003-09 Impact factor: 4.296
Authors: Carlos Capella-Peris; Mary M Cosgrove; Irene C Chrismer; M Sonia Razaqyar; Jeffrey S Elliott; Anna Kuo; Magalie Emile-Backer; Katherine G Meilleur Journal: Patient Date: 2020-08 Impact factor: 3.883
Authors: Josine M de Winter; Joery P Molenaar; Michaela Yuen; Robbert van der Pijl; Shengyi Shen; Stefan Conijn; Martijn van de Locht; Menne Willigenburg; Sylvia Jp Bogaards; Esmee Sb van Kleef; Saskia Lassche; Malin Persson; Dilson E Rassier; Tamar E Sztal; Avnika A Ruparelia; Viola Oorschot; Georg Ramm; Thomas E Hall; Zherui Xiong; Christopher N Johnson; Frank Li; Balazs Kiss; Noelia Lozano-Vidal; Reinier A Boon; Manuela Marabita; Leonardo Nogara; Bert Blaauw; Richard J Rodenburg; Benno Küsters; Jonne Doorduin; Alan H Beggs; Henk Granzier; Ken Campbell; Weikang Ma; Thomas Irving; Edoardo Malfatti; Norma B Romero; Robert J Bryson-Richardson; Baziel Gm van Engelen; Nicol C Voermans; Coen Ac Ottenheijm Journal: J Clin Invest Date: 2020-02-03 Impact factor: 14.808
Authors: Josine M de Winter; Barbara Joureau; Eun-Jeong Lee; Balázs Kiss; Michaela Yuen; Vandana A Gupta; Christopher T Pappas; Carol C Gregorio; Ger J M Stienen; Simon Edvardson; Carina Wallgren-Pettersson; Vilma-Lotta Lehtokari; Katarina Pelin; Edoardo Malfatti; Norma B Romero; Baziel G van Engelen; Nicol C Voermans; Sandra Donkervoort; C G Bönnemann; Nigel F Clarke; Alan H Beggs; Henk Granzier; Coen A C Ottenheijm Journal: Ann Neurol Date: 2016-04-30 Impact factor: 10.422
Authors: D Natera-de Benito; A Nascimento; A Abicht; C Ortez; C Jou; J S Müller; T Evangelista; A Töpf; R Thompson; C Jimenez-Mallebrera; J Colomer; H Lochmüller Journal: J Neurol Date: 2016-01-11 Impact factor: 4.849
Authors: Josine M de Winter; Charlotte Gineste; Elisa Minardi; Lorenza Brocca; Maira Rossi; Tamara Borsboom; Alan H Beggs; Monique Bernard; David Bendahan; Darren T Hwee; Fady I Malik; Maria Antonietta Pellegrino; Roberto Bottinelli; Julien Gondin; Coen A C Ottenheijm Journal: Hum Mol Genet Date: 2021-06-26 Impact factor: 6.150